The Company will use the proceeds of the First Tranche of the Offering towards advancing its Alzheimer’s Disease (" AD ”) program including the opening of its first U.S. AD clinic, general and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback